Johnson & Johnson today reported the results of new Phase 3 data for seltorexant, a novel selective orexin-2 receptor antagonist, as an add-on treatment for adults and elderly patients with major depressive disorder (MDD) and insomnia symptoms...
Indoco is a pharmaceutical company with a large global presence that is completely integrated and focused on research. With a human capital of over 6000 personnel, including over 400 highly qualified scientists and field workers who represent the
Teva Pharmaceuticals, the U.S. branch of Teva Pharmaceutical Industries Ltd., shared the promising new long-term data of its schizophrenia drug portfolio at the 2025 Psych Congress Annual Meeting in San Diego, California.
Agilus Diagnostics, the flagship provider of diagnostic services in India, is a wholly-owned subsidiary of Fortis Healthcare Ltd., and has made the announcement of the introduction of its AgilusEDGE Comprehensive Genomic Profile
Ronnie Coleman Signature Series (RCSS) has formally established an exclusive strategic agreement with Bright Lifecare (HealthKart), one of India's top health and wellness organizations, marking a significant milestone for the country's fitness and
Fortis Healthcare is prioritizing obesity treatment and developing obesity clinics throughout India to address increasing demand for weight-loss drugs and therapies.The initiative is taking place as India is set to be the world's second-largest...
Maxivision Super Speciality Eye Hospitals, one of India’s fastest-growing eye care chains, launches a first-of-its-kind initiative in Madhapur, Hyderabad to address the rapidly growing problem of myopia, furthering its mission to combat the...
First-of-its-kind digital health programme on Vidal Health’s platform will offer an end- to-end, convenient and cashless experience, making HPV vaccine more accessible Collaboration is part of Vidal Health’s efforts to provide preventive
.jpeg "Indian Pharma Targets Rs 800 Cr Insulin Pen Market Post Novo")
Novo Nordisk's declaration to put an end to its Penfill and FlexPen products in India by December 2023, Indian pharmaceutical companies like Eris Lifesciences, Wockhardt, and Lupin, are getting ready to capitalize the local human insulin
Alkem Laboratories announced the launch of Pertuza injection 420mg/14mL, a pertuzumab biosimilar that has been developed in India and can be used in HER2-positive breast cancer. With this achievement, Alkem aims to provide better access to...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")